XNAS: CLLS
Cellectis (ADR) Live Stock Price Today, Share Analysis and Chart
about
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the fi...
Read More
2.62
-0.17
(-6.09%)
63,177.1
XNAS Volume
High volume+loss today
XNAS 06 Aug, 2026 1:59 PM (EDT)
Board Meeting
The board meeting for Cellectis (ADR) is scheduled for today, for the purpose of Cellectis SA Second Quarter Earnings Results for 2026
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Cellectis (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..